GL1X · GenesisL1 explorer

MolNFT v1 · #4118 · protein + DNA

Diphtheria tox repressor (C102D MUTANT)/TOX DNA operator complex

1DDN · 33 base DNA containing toxin operator: “Diphtheria tox repressor (C102D MUTANT)/TOX DNA operator complex”. X-ray diffraction, 1 ligand (NI), 11 pockets (best druggability 0.57). MolNFT v1 #4118 on GenesisL1: 3D structure, binding…

PDB
1DDN
Type
protein + DNA
Length
538 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
33 base DNA containing toxin operator; Diphtheria tox repressor
UniProt
P33120
Ligands
NI
Pockets
11 · best druggability 0.57

Structure

x-ray diffraction · 3 distinct chains · 69% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
E33 base DNA containing toxin operatordna33——
F33 base DNA containing toxin operatordna33——
A, B, C, DDiphtheria tox repressorprotein11869% helix, 5% strandP33120

Ligands and binding sites

  • NI · Nickel (II) ion · metal · 8 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13570.570.7628empty
22690.510.7528empty
32250.480.7526empty
42170.430.7322empty
52070.420.7223empty

Interfaces

11 interfaces between chains.

  • E–F · 1421 Ų buried · 136 hydrogen bonds · nucleic-nucleic
  • C–D · 843 Ų buried · 15 hydrogen bonds · protein-protein
  • A–B · 841 Ų buried · 10 hydrogen bonds · protein-protein
  • E–B · 486 Ų buried · 12 hydrogen bonds · protein-nucleic
  • F–D · 481 Ų buried · 9 hydrogen bonds · protein-nucleic

Compared structures

  • 1DDN · Diphtheria tox repressor (C102D MUTANT)/TOX DNA operator complex · the same entry in another collection · chain E against E, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.